2019
DOI: 10.1080/09273948.2019.1672198
|View full text |Cite
|
Sign up to set email alerts
|

Retinal Function in Patients with Adalimumab Treatment: Long-term Follow-up with Microperimetry

Abstract: Purpose: To examine the effects of a biological treatment (adalimumab) on visual function in patients with ankylosing spondylitis and in uveitic patients without macular edema during one-year treatment with adalimumab. Methods: Sixteen eyes of eight consecutive Caucasian patients treated with adalimumab were followed up using microperimetry (MAIA; CenterVue, Padova, Italy). Five patients had ankylosing spondylitis without uveitis, three patients had panuveitis without macular edema. Macular sensitivity and mac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…29 In an eye with 20/20 BCVA, nonproliferative diabetic retinopathy, and no clinical findings of retinal hemorrhage or macular edema to explain new symptoms of central visual impairment (Case 4, Figure 4), we were able to correlate focal In Case 5 (Figure 5), we demonstrated the potential to use sequential registered microperimetry RS maps and OCT B-scans to assess response to immunosuppressive therapy in an eye with visual field loss due to recurrent PIC. 30 We observed a clear association between reduced RS and the severity of EZ disruption imaged with OCT. As shown by other investigators, the area of transient EZ disruption also appeared hyperautofluorescent on FAF. 31 Restoration of the EZ occurring with oral corticosteroids was accompanied by recovery of RS.…”
Section: Discussionmentioning
confidence: 56%
“…29 In an eye with 20/20 BCVA, nonproliferative diabetic retinopathy, and no clinical findings of retinal hemorrhage or macular edema to explain new symptoms of central visual impairment (Case 4, Figure 4), we were able to correlate focal In Case 5 (Figure 5), we demonstrated the potential to use sequential registered microperimetry RS maps and OCT B-scans to assess response to immunosuppressive therapy in an eye with visual field loss due to recurrent PIC. 30 We observed a clear association between reduced RS and the severity of EZ disruption imaged with OCT. As shown by other investigators, the area of transient EZ disruption also appeared hyperautofluorescent on FAF. 31 Restoration of the EZ occurring with oral corticosteroids was accompanied by recovery of RS.…”
Section: Discussionmentioning
confidence: 56%